CABLIVI

CABLIVI is a prescription treatment used in combination with PEX and immunosuppression to treat adults with acquired/immune-mediated thrombotic thrombocytopenic purpura (aTTP/iTTP*)... CABLIVI helped return platelet counts to normal significantly faster when added to PEX and immunosuppression... Learn about CABLIVI (caplacizumab-yhdp), for adults with acquired/immune-mediated thrombotic thrombocytopenic purpura (aTTP/iTTP) in combination with plasma exchange immunosuppressive therapy. Please see Important Safety Information and full PI on website.

Also known as: Genzyme Corporation